J&J | JNJ - Cost Of Sales


J&J reported $8.08B in Cost of Sales for its fiscal quarter ending in September of 2026.





Cost Of Sales Change Date
AbbVie USD 4.29B 73M Jun/2026
Abbott USD 5.94B 642M Jun/2026
Amgen USD 1.87B 271M Jun/2026
AstraZeneca USD 2.52B 2.73B Jun/2026
Baxter International USD 1.93B 118M Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Biogen USD 945.1M 147.6M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
CONMED USD 146.03M 12.43M Jun/2026
Cooper Companies USD 401.3M 7.5M Jun/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Eli Lilly USD 3.27B 309M Jun/2026
Gilead Sciences USD 1000M 445M Jun/2026
GlaxoSmithKline GBP 2.07B 192M Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
J&J USD 8.08B 80M Sep/2026
Medtronic USD 3.83B 26M Jun/2026
Merck USD 3.14B 200M Jun/2026
Merit Medical Systems USD 203.68M 6.6M Jun/2026
Novartis USD 3.71B 251M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Regeneron Pharmaceuticals USD 576.5M 92.9M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teva Pharmaceutical Industries USD 1.98B 30M Jun/2026
Vertex Pharmaceuticals USD 489.2M 96.4M Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026
Zoetis USD 704M 32M Jun/2026